bg
I

I-Mab (IMAB)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About I-Mab (IMAB)

I-Mab is a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune ... Read more

  • USD1.80
  • USD1.81
  • USD1.78
  • USD3.45
  • -3.20%
  • 28M
  • 163.23k
  • 223.93k
  • 145M
  • 1.16
  • -43.10%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.